Winningham Rick E — SEC insider filings
SEC reporting owner CIK 1302443. 50 insider filings on record with FilingPulse; latest filed 2026-09-24.
Transaction summary — filings shown
Covers all 50 filings on record, filed 2020-08-10 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 62,808 shares, $2,864,126 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 65.
- Largest priced transaction: sale of 5,500 shares @ $180.86 ($994,728) in Jazz Pharmaceuticals plc, filed 2025-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | 11 | — | 6 legs · 12,808 sh · $2,304,626 | 14 |
| Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER, Director | 39 | — | 1 leg · 50,000 sh · $559,500 | 51 |
Insider filings — Winningham Rick E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Disposition to issuer (D): 1,382,272 · Disposition to issuer (D): 151,875 · Disposition to issuer (D): 76,875 · Disposition to issuer (D): 23,400 · Disposition to issuer (D): 92,567 · Disposition to issuer (D): 515,000 (derivative) | EDGAR |
| 2026-09-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,692 @ $241.39 · Tax withholding (F): 14 @ $244.64 | EDGAR |
| 2026-08-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 20,034 @ $16.95 | EDGAR |
| 2026-08-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-05-27 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 3,415 @ $138.08 · Sale (S): 2,741 @ $241.57 · Option exercise (M): 3,415 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 20,038 @ $16.55 | EDGAR |
| 2026-04-03 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2026-02-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 74,975 @ $19.66 | EDGAR |
| 2025-11-21 | 4 | Theravance Biopharma, Inc. (TBPH) | Gift (G): 9,900 @ $0 · Gift (G): 9,900 @ $0 · Tax withholding (F): 56,817 @ $17.90 | EDGAR |
| 2025-11-20 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 5,500 @ $180.86 | EDGAR |
| 2025-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,394 @ $13.39 | EDGAR |
| 2025-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,507 @ $0 · Tax withholding (F): 1,805 @ $111.25 | EDGAR |
| 2025-06-25 | 4 | Theravance Biopharma, Inc. (TBPH) | Gift (G): 20,000 @ $0 | EDGAR |
| 2025-06-17 | 4 | Theravance Biopharma, Inc. (TBPH) | Gift (G): 9,600 @ $0 · Gift (G): 9,600 @ $0 | EDGAR |
| 2025-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,364 @ $9.45 | EDGAR |
| 2025-03-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 2,178 @ $9.35 | EDGAR |
| 2025-02-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 35,129 @ $9.66 | EDGAR |
| 2024-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,997 @ $9.97 | EDGAR |
| 2024-11-19 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 3,193 @ $9.57 | EDGAR |
| 2024-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,997 @ $8.22 | EDGAR |
| 2024-08-09 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 3,252 @ $7.83 | EDGAR |
| 2024-08-06 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,731 @ $0 · Tax withholding (F): 1,484 @ $111.35 | EDGAR |
| 2024-05-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,997 @ $9.10 | EDGAR |
| 2024-05-17 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 2,068 @ $9.85 | EDGAR |
| 2024-04-04 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2024-03-19 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 2,704 @ $8.64 · Gift (G): 7,000 @ $0 · Gift (G): 3,900 @ $0 · Gift (G): 3,900 @ $0 | EDGAR |
| 2024-02-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 37,196 @ $8.92 | EDGAR |
| 2023-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,804 @ $10.37 | EDGAR |
| 2023-08-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,804 @ $9.70 | EDGAR |
| 2023-08-15 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 3,075 @ $0 · Sale (S): 1,241 @ $138.16 | EDGAR |
| 2023-05-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,804 @ $11.21 | EDGAR |
| 2023-03-03 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 330,000 @ $0 | EDGAR |
| 2023-02-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 37,420 @ $10.44 | EDGAR |
| 2022-12-16 | 4 | Theravance Biopharma, Inc. (TBPH) | Gift (G): 9,000 · Sale (S): 50,000 @ $11.19 | EDGAR |
| 2022-11-22 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,804 @ $10.85 | EDGAR |
| 2022-08-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 15,804 @ $9.34 | EDGAR |
| 2022-08-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,561 @ $0 · Sale (S): 1,089 @ $152.32 | EDGAR |
| 2022-05-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,025 @ $8.74 | EDGAR |
| 2022-03-01 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 170,000 @ $0 · Grant/award (A): 515,000 (derivative) @ $0 | EDGAR |
| 2022-02-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 22,710 @ $9.61 | EDGAR |
| 2021-11-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,404 @ $8.36 | EDGAR |
| 2021-08-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,404 @ $14.05 | EDGAR |
| 2021-08-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,306 @ $147.96 | EDGAR |
| 2021-08-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,246 @ $0 | EDGAR |
| 2021-05-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 11,404 @ $17.80 | EDGAR |
| 2021-02-23 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 110,348 @ $18.79 | EDGAR |
| 2021-02-10 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 170,000 @ $0 | EDGAR |
| 2020-11-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 13,946 @ $17.21 | EDGAR |
| 2020-08-24 | 4 | Theravance Biopharma, Inc. (TBPH) | Tax withholding (F): 13,946 @ $18.22 | EDGAR |
| 2020-08-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 2,705 @ $0 · Sale (S): 931 @ $125.87 · Grant/award (A): 6,765 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1302443 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs